SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,200 | -29.8% | 14,000 | 0.0% | 0.00% | – |
| Q2 2023 | $15,960 | -24.0% | 14,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,000 | -25.8% | 14,000 | -26.3% | 0.00% | – |
| Q4 2022 | $28,310 | -2.4% | 19,000 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -32.6% | 19,000 | 0.0% | 0.00% | – |
| Q2 2022 | $43,000 | +43.3% | 19,000 | +46.2% | 0.00% | – |
| Q1 2022 | $30,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 415,000 | $942,000 | 0.18% |
| RA Capital Management | 723,549 | $1,642,000 | 0.04% |
| Duquesne Family Office | 100,000 | $227,000 | 0.02% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| Ergoteles LLC | 93,598 | $212,000 | 0.01% |
| Virtu Financial LLC | 11,223 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $86,000 | 0.00% |
| Renaissance Technologies | 247,000 | $561,000 | 0.00% |
| UBS Group AG | 13,463 | $31,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 38,776 | $88,000 | 0.00% |